{"chunk_id": "Integrated Maternal and Perinatal Care Guideline_23_10_2024_0__chunk_1008", "source": "Integrated Maternal and Perinatal Care Guideline_23_10_2024_0", "text": "ll decrease the risk \nfor transmission\no For those who are HIV negative, but declines PreP, the need for maternal antivirals (tenofovir-TDF) for \nVTP is dependent on the HBV viral load (TDF indicated if viral load > 200 000 IU/ml) and where this \nnot available, on a positive HBeAg serological status.\no Where TDF is indicated for VTP, it can be started between 28 and 32 weeks and continued until 12 \nweeks post-delivery\no The WHO also recommends, where viral load or HBeAg testing (or results) are"}